Skip to main content

Box 37

 Container

Contains 10 Results:

Correspondence, 1969

 File — Box: 37, Folder: 1
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1969

Press and Public reaction, August 1969

 File — Box: 37, Folder: 2
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: August 1969

Press and public reaction, September 1969-June 1970

 File — Box: 37, Folder: 3
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: September 1969-June 1970

Aspercreme, TEA/S, 1980-1982

 File — Box: 37, Folder: 5
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1980-1982

Aspercreme, 1980-1983

 File — Box: 37, Folder: 6
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1980-1983

Pfizer "UnBurn", 1970-1972

 File — Box: 37, Folder: 7
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1970-1972

Council of Better Business Bureaus (Vacheron, David L.), 1975-1976

 File — Box: 37, Folder: 4
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1975-1976

Department of Health, Education and Welfare advisory work, 1954-1972; 1979

 File — Box: 37, Folder: 8
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1954-1972; 1979

Miscellaneous advisory projects (drug-related), 1970-1984

 File — Box: 37, Folder: 9
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1970-1984

National Formulary, 1969, 1971-1973

 File — Box: 37, Folder: 10
Scope and Contents From the Series: The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates: 1969, 1971-1973